255 related articles for article (PubMed ID: 27058223)
1. Axonal damage in central and peripheral nervous system inflammatory demyelinating diseases: common and divergent pathways of tissue damage.
Barnett MH; Mathey E; Kiernan MC; Pollard JD
Curr Opin Neurol; 2016 Jun; 29(3):213-21. PubMed ID: 27058223
[TBL] [Abstract][Full Text] [Related]
2. Demyelinating neuropathies.
Zhou L; Griffin JW
Curr Opin Neurol; 2003 Jun; 16(3):307-13. PubMed ID: 12858066
[TBL] [Abstract][Full Text] [Related]
3. Secondary axon atrophy and neurological dysfunction in demyelinating neuropathies.
Hanemann CO; Gabreels-Festen AA
Curr Opin Neurol; 2002 Oct; 15(5):611-5. PubMed ID: 12352005
[TBL] [Abstract][Full Text] [Related]
4. Experimental models of peripheral neuropathies.
Notterpek L; Tolwani RJ
Lab Anim Sci; 1999 Dec; 49(6):588-99. PubMed ID: 10638493
[TBL] [Abstract][Full Text] [Related]
5. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory demyelination is not central to the pathogenesis of multiple sclerosis.
Brück W
J Neurol; 2005 Nov; 252 Suppl 5():v10-5. PubMed ID: 16254696
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of axonal damage in inflammatory central nervous system diseases.
Neumann H
Curr Opin Neurol; 2003 Jun; 16(3):267-73. PubMed ID: 12858061
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection in the peripheral nervous system: rationale for more effective therapies.
Höke A
Arch Neurol; 2006 Dec; 63(12):1681-5. PubMed ID: 17172606
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic analysis of 124 biopsy-proven peripheral nerve diseases.
Hong SM; Ha H; Suh JH; Kim KK; Khang SK; Ro JY; Park SH
J Korean Med Sci; 2000 Apr; 15(2):211-6. PubMed ID: 10803700
[TBL] [Abstract][Full Text] [Related]
10. Peripheral neuropathies: Biomarkers for axonal damage in immune-mediated neuropathy.
Jacobs BC; Willison HJ
Nat Rev Neurol; 2009 Nov; 5(11):584-5. PubMed ID: 19888315
[No Abstract] [Full Text] [Related]
11. [Axonal involvement in dysimmune neuropathies].
Vallat JM
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S5-11. PubMed ID: 18087224
[TBL] [Abstract][Full Text] [Related]
12. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage.
Brück W
J Neurol; 2005 Nov; 252 Suppl 5():v3-9. PubMed ID: 16254699
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.
Kornek B; Storch MK; Weissert R; Wallstroem E; Stefferl A; Olsson T; Linington C; Schmidbauer M; Lassmann H
Am J Pathol; 2000 Jul; 157(1):267-76. PubMed ID: 10880396
[TBL] [Abstract][Full Text] [Related]
14. Axonal CIDP: a premature concept?
Feasby TE
Muscle Nerve; 1996 Mar; 19(3):372-4. PubMed ID: 8606704
[No Abstract] [Full Text] [Related]
15. Membrane property abnormalities in simulated cases of mild systematic and severe focal demyelinating neuropathies.
Stephanova D; Daskalova M
Eur Biophys J; 2008 Feb; 37(2):183-95. PubMed ID: 17786424
[TBL] [Abstract][Full Text] [Related]
16. Similarities between inherited demyelinating neuropathies and Wallerian degeneration: an old repair program may cause myelin and axon perturbation under nonlesion conditions.
Martini R; Klein D; Groh J
Am J Pathol; 2013 Sep; 183(3):655-60. PubMed ID: 23831295
[TBL] [Abstract][Full Text] [Related]
17. [Axonal damage and its significance for the concept of neurodegeneration in multiple sclerosis].
Recks MS; Bader J; Kaiser CC; Schroeter M; Fink GR; Addicks K; Kuerten S
Fortschr Neurol Psychiatr; 2011 Mar; 79(3):161-70. PubMed ID: 21394707
[TBL] [Abstract][Full Text] [Related]
18. In response to "Correlations of nerve conduction measures in axonal and demyelinating polyneuropathies".
Caliandro P; Stålberg E; Padua L
Clin Neurophysiol; 2008 Jul; 119(7):1694-5. PubMed ID: 18467169
[No Abstract] [Full Text] [Related]
19. Neurodegeneration in multiple sclerosis.
Mey GM; Mahajan KR; DeSilva TM
WIREs Mech Dis; 2023 Jan; 15(1):e1583. PubMed ID: 35948371
[TBL] [Abstract][Full Text] [Related]
20. Relapsing demyelinating disease affecting both the central and peripheral nervous systems.
Zéphir H; Stojkovic T; Latour P; Lacour A; de Seze J; Outteryck O; Maurage CA; Monpeurt C; Chatelet P; Ovelacq E; Vermersch P
J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1032-9. PubMed ID: 18208860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
